Celsius Holdings, Inc. Key Metrics

2 years of history · ending 2025-12-31 · SEC EDGAR

Forensics

Three classic accounting-quality scores. F-Score (0-9, higher = better fundamentals); M-Score (>-1.78 flags possible manipulation); Z-Score (>2.99 = safe, <1.81 = distressed). Use together — single-score readings are noisy.

F-Score (Piotroski 0-9)

Z-Score (Altman; <1.81 = distress)

Per Share Metrics

Turnover & Efficiency Analysis (days)

Expense Ratios

Working Capital Analysis

Valuation Multiples

Cash-Flow Multiples

Enterprise Value Multiples

52-Week Range

Trailing Returns

ROIC vs WACC

Yields

Capital Deployment Yields

Liquidity & Leverage Ratios

Earnings Quality (OCF/NI · FCF/NI · Sloan Accruals)

EPS (Diluted)
$0
Book Value Per Share
$5
Free Cash Flow Per Share
$1
Cash Per Share
$2
Revenue Per Share
$10
OCF Per Share
$1
Return on Equity
13.7%
Return on Assets
3.1%
Return on Invested Capital
10.8%
Debt to Equity
0.57
Current Ratio
1.68
Quick Ratio
1.37
Asset Turnover
0.73
Days Sales Outstanding
109.63
Days Payables Outstanding
40.34
Days Inventory On Hand
98.77
Cash Conversion Cycle
168.06
R&D / Revenue
0.1%
SBC / Revenue
1.1%
Capex / Revenue
1.4%
Working Capital
$732M
Net Current Asset Value
$-367M
Invested Capital
$1.86B
OCF / Net Income
3.33
FCF / Net Income
2.99
Accruals Ratio (Sloan)
-4.9%
Net Debt
$278M
Net Debt / EBITDA
1.63
Interest Coverage
2.88
Cash Coverage
7.34
Capex Coverage
9.97
Tangible Common Equity
$152M
TCE / Total Assets
3.0%
Goodwill / Total Assets
17.9%
NOPAT
$122M
Cash ROIC
28.6%
WC / Revenue
29.1%
Capex / D&A
1.22
Reinvestment Rate
4.7%
Total Payout Ratio
5.3%
Asset Growth vs Revenue Growth
104.2%
Revenue 5Y CAGR
80.7%
EPS 5Y CAGR
66.2%
FCF 5Y CAGR
158.1%
EBITDA 5Y CAGR
84.2%
Book Value 5Y CAGR
62.5%
Stock Price (FY-end)
$46
Market Cap
$11.66B
P/E Ratio
107.96
P/S Ratio
4.64
P/B Ratio
9.87
P/TB Ratio
76.71
P/OCF Ratio
32.44
P/FCF Ratio
36.06
Enterprise Value
$11.94B
EV / EBITDA
70.01
EV / Sales
4.75
EV / FCF
36.92
FCF Yield
2.8%
Shareholder Yield
-0.2%
Buyback Yield
0.0%
R&D Yield
0.0%
Capex Yield
0.3%
Operating Leverage
-0.11
Graham Number
$7
Shares Variation (YoY)
7.4%
Beta (5Y)
1.65
Cost of Equity
12.8%
Cost of Debt (after tax)
6.2%
WACC
12.4%
ROIC - WACC Spread
-1.6%
52W High
$65
52W Low
$21
Trailing Return 1Y
72.9%
Trailing Return 5Y
219.1%
F-Score (Piotroski)
4.00
Z-Score (Altman)
4.01

Earnings Forecasts

Per-quarter consensus estimates + actuals + beat/miss surprise. Sourced from Finnhub (Wall Street consensus aggregation).

Source caveat: Finnhub free tier returns the consensus mean only — analyst high / low / dispersion + analyst counts require a paid plan. A "$5.00 consensus" line above could mean "20 analysts at exactly $5" (high conviction) or "10 at $5.50, 10 at $4.50" (split). Treat single-line consensus accordingly.

EPS — Consensus vs Actual

Revenue — Consensus vs Actual

Stock Price on Earnings Dates

Celsius Holdings, Inc. — Effective Tax Rate ReconciliationNEW

Bridges from the federal statutory rate (21% post-TCJA) to the effective tax rate via the issuer's tax-note reconciliation lines. Sourced from EffectiveIncomeTaxRateReconciliation* flat CompanyFacts concepts. Conditional lines (R&D credits, FDII, SBC, valuation allowance, etc.) only render when the issuer discloses them. Persistent divergence between accrual tax expense and cash taxes paid is a leading signal for deferred-tax buildup.

Effective Rate Trend

Reconciliation LineFY2020FY2021FY2022FY2023FY2024FY2025
Federal Statutory Rate21.00%21.00%21.00%21.00%21.00%21.00%
State & Local Income Taxes4.40%-12.50%-3.90%4.70%6.20%3.30%
Foreign Rate Differential0.00%0.10%3.30%
Other Adjustments
FDII Deduction1.20%
SBC (Nondeductible)-3.40%-5.20%1.70%
Valuation Allowance Change-0.30%-0.70%
Tax Law Change
Effective Tax Rate2.30%1.97%-22.70%22.20%25.70%13.60%

Cash vs Accrual

ItemFY2020FY2021FY2022FY2023FY2024FY2025
Income Tax Expense (Accrual)$116.0K−$8.0M$34.6M$64.9M$50.0M$17.0M
Income Taxes Paid (Cash)$64.2M

Celsius Holdings, Inc. — M&A AcquisitionsNEW

Per-deal acquisition disclosures sourced from us-gaap:BusinessAcquisitionAxis dimensional XBRL. Each card surfaces the deal's purchase-price allocation (goodwill vs intangibles vs liabilities), contingent consideration (unpaid earn-outs), and pro-forma combined-entity numbers. Probability-of-Success (PoS) factor on biotech targets is the ASC 805 contingent-consideration valuation — higher = closer to commercialization, higher implied target value.

Alani Nu

Total Consideration

$2.06B

Purchase-Price Allocation

Goodwill

$734.4M

Intangibles

$1.22B

Contingent Earn-Out

$25.0M

Rockstar

Total Consideration

$307.6M

Purchase-Price Allocation

Goodwill

$109.8M

Intangibles

$181.5M

Big Beverages Contract Manufacturing LLC

Purchase-Price Allocation

Goodwill

$58.3M

Alani Nu And Rockstar Energy

Pro-Forma Combined Entity

Revenue

$3.00B

Net Income

+$218.7M

Celsius Holdings, Inc. — RestructuringNEW

Per-category restructuring disclosures sourced from us-gaap:RestructuringCostAndReserveAxis dimensional XBRL. Negative charges indicate reversals of prior accruals (a sign the original estimate was too aggressive — flattering current-period earnings).

As of 2025-12-31

CategoryClassP&L ChargeCash PaidReserve Balance
Contract TerminationContract Termination+$328M$70M